Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Repligen reported $100.82M in Gross Profit on Sales for its fiscal quarter ending in March of 2023.

Gross Profit On Sales Change
Agilent A:US USD 924M 44M
Align Technology ALGN:US USD 660.65M 42.95M
BioMarin Pharmaceutical BMRN:US USD 469.87M 59.62M
Bristol-Myers Squibb BMY:US USD 8.77B 114M
Bruker BRKR:US USD 359.7M 5.9M
Catalent CTLT:US USD 387M 129M
Charles River Laboratories CRL:US USD 377.65M 21.23M
Danaher DHR:US USD 4.37B 569M
Dentsply International XRAY:US USD 523M 6M
Exact Sciences EXAS:US USD 445.58M 39.74M
General Electric GE:US USD 3.54B 2.49B
Henry Schein HSIC:US USD 966M 33M
Illumina ILMN:US USD 655M 17M
IQVIA Holdings Inc IQV:US USD 1.25B 78M
Myriad Genetics MYGN:US USD 122M 1.9M
NanoString Technologies NSTG:US USD 12.93M 366K
OraSure Technologies OSUR:US USD 65.85M 16.26M
Pacific Biosciences Of California PACB:US USD 9.76M 916K
Patterson Companies PDCO:US USD 342.96M 14.87M
Peregrine Pharmaceuticals PPHM:US USD 9.82M 5.68M
Pfizer PFE:US USD 13.26B 1.21B
Repligen RGEN:US USD 100.82M 4.75M
Thermo Fisher Scientific TMO:US USD 4.27B 462M
Waters WAT:US USD 400.29M 110.03M
West Pharmaceutical Services WST:US USD 271.3M 9.2M